Source link : https://newshealth.biz/health-news/non-surgical-option-approved-for-recurrent-low-grade-bladder-cancer/
(MedPage Today) — The FDA approved mitomycin intravesical solution (Zusduri) as a nonsurgical option for recurrent low-grade, intermediate-risk non-muscle invasive bladder cancer (NMIBC). The product won the indication despite a negative recommendation… Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/116047 Author : Publish date : 2025-06-12 19:27:00 Copyright for syndicated content belongs to the linked Source.
The post Non-Surgical Option Approved for Recurrent Low-Grade Bladder Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-12 19:27:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8